ESTRO 2025 - Abstract Book

S1124

Clinical – Head & neck

ESTRO 2025

authorities (N=14; 20.3%) and one in ten (n=7; 10.1%) did not search for support, despite admitting that had needed it.

Conclusion: Romanian HN patients face various financial challenges after diagnosis, having significant out-of-pocket expenses compared to their income.

Keywords: financial toxicity, head and neck, healthcare

References: 1. Carrera PM, Curigliano G, Santini D, et al. ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer. ESMO Open. 2024;9(5):102992. doi:10.1016/j.esmoop.2024.102992 2. Azzani M, Atroosh WM, Anbazhagan D, Kumarasamy V, Abdalla MMI. Describing financial toxicity among cancer patients in different income countries: a systematic review and meta-analysis. Front Public Health. 2024;11:1266533. Published 2024 Jan 2. doi:10.3389/fpubh.2023.1266533 3. Raggini E, Mattavelli D, Zigliani G, Bossi P, Piazza C. Measuring financial toxicity in head and neck cancer: a systematic review. Acta Otorhinolaryngol Ital. 2024;44(1):1-12. doi:10.14639/0392-100X-N2762

4247

Digital Poster The bacterial composition of Head and Neck tumours can resolve hypoxia/immune gene expression-based prognosis in patients with mixed patterns Jacopo Iacovacci, Tiziana Rancati Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy Purpose/Objective: Head and Neck squamous cell carcinoma (HNSCC) is generally characterised by a highly hypoxic and immunosuppressive tumour microenvironment resulting in 5-year survival rates of 28-67% [1]. Commensal bacteria,